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Abstract
Chondroid syringoma (CS) of the orbit is an extremely rare benign neoplasm. To the best of our knowledege, this
is the second case reported in the english litérature.
We report a case of a 41-year-old woman with orbital CS. This tumor developed slowly over 8 years causing
indolor, no axil, exophtalmos of the left eye. Computed tomography demonstrated an isodense intraorbital tumor
with homogeneous enhancement without bony erosion. On Magnetic resonance imaging the tumor was
isointense on T1-weighted imaging, slightly hyper intense on T2-weighted imaging, and enhanced after
Gadolinium administration. The patient was operated via left lateral orbitotomy. At surgery the mass was well
circumscribed, extraconal, very firm and did not invade or adhere to other structures. The tumor was removed in
toto. The diagnosis was confirmed by histopathological examination, the lesion was nodular, and there was
differentiation toward the adnexal ductal epithelium with chondromyxoid and adipocytic differentiation in the
stroma. No recurrence was seen with one year follow-up.
CS should be included in the differential diagnosis of intra-orbital tumors. Complete resection remains the best
therapeutic option to prevent recurrence. Close followup is recommended because malignant transformation,
although rare, is possible.
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Introduction
Chondroid syringoma (CS) are rare mixed tumours of
sweat-gland which were first described by Billroth in
1859, that have both a bening and malignant form.
Hirsch and Helwig in 1961 [1] gave them the appella-
tion CS, because of the presence of sweat gland ele-
ments which are set in a cartilaginous stroma. The
commonest sites are the scalp, cheek, nose, upper lip,
chin, and the forehead.
CS of the orbit are extremely rare. In the better of our
knowledege, only one case has been reported in the eng-
lish litérature [2]. Here we report an unusual case of a
patient who underwent complete resection of a intraor-
bital CS. The clinical presentation, histologycal findings
and treatment, with review of the relevant literature, are
discussed.
Case report
A 41-year-old woman presented with a history of left
exophtalmos for 8 years and deterioration of visual acuity
in the last 8 months. His medical and ocular histories
were unremarkable. Physical examination disclosed no
system abnormality except ocular findings. There was an
indolor left exophtalmos, no axil with downward displace-
ment of the globe. Abduction of the left eye was slightly
restricted. Partial visual field defect was noted. Visual
acuity was 8/10 in the left eye and 10/10 in the right eye.
Cranial CT scan demontrated a superolaterally solid
tumor, well circumscribed with homogeneous enhance-
ment without bone erosion (Figure 1A). MRI showed a
round mass that was extraconal, isointensity on T1-
weighted imaging, slightly hyperintensity on T2-weighted
imaging and enhanced after intravenous contrast adminis-
tration (Figure 1B, C and 1D). The globe was displaced
anteriorly. The optic nerve was medially displaced by the
intervening mass. Our preoperative diagnoses was pleo-
morphic adenoma and adenoid cystic carcinoma. The
tumor was removed completely through lateral orbitotomy
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was extraconal, very firm, enucleated easily and schowed
no invasion or adhesion to other structures, including
skin, globe, extraocullar muscles, lacrimal gland, and orbi-
tal bone. The diagnosis of CS was confirmed by histo-
pathological examination. Gross pathologic analysis
revealed well-encapsulated tan tissue measuring 2 × 3 ×
1,5 cm (Figure 2a). No areas of hemorrhage or necrosis
were noted. Histologically, the lesion was nodular, and
there was differentiation toward the adnexal ductal epithe-
lium with chondromyxoid and adipocytic differentiation in
the stroma (Figure 2b). Early postoperative CT image
schows complete removal with good orbital reconstruction
(Figure 2c). The postoperative course was uneventful. The
patient was discharged 4 days after the operation without
any complication. Eye motility, visual acuity and cosmetic
appearance improved satisfactorily. No recurrence has
been seen with one year of follow-up.
Figure 1 (A): Cranial CT scan demontrated an intra-orbital tumor, well circumscribed with homogeneous enhancement without bone
erosion.( B, C and D): MRI showed a round mass that was extraconal, isointensity on T1-weighted imaging, slightly hyperintensity on T2-
weighted imaging and enhanced after intravenous contrast administration.
Figure 2 (a): gross pathologic analysis revealed well-e n c a p s u l a t e dt a nt i s s u em e a s u r i n g2×3×1 , 5c m . No areas of hemorrhage or
necrosis were noted. (b): a photomicrograph of the surgical specimen shows an encapsulated proliferation of nonbranching ducts set in
chondromyxoid stroma. (hematoxylin and eosin stain, ×100). (c): postoperative CT image schows complete removal with good orbital
reconstruction.
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Chondroid syringoma (CS) is a rare, benign, skin appen-
dagal tumor, first described by Billorth in 1859 for a
g r o u po ft u m o r so ft h es a l i v a r yg l a n dt h a tc o n t a i n e d
varying amounts of mucoid and cartilaginous material
[3]. Virchow and Minssen referred to them as mixed
tumors with both epithelial and mesenchymal origin [4].
The term « chondroid syringoma » was coined by Hirsh
and Helwig (1961) to refer to a type of skin tumour origi-
nating in the apocrine sweat glands, comprised of gland-
ular elements and stroma, similar to cartilage (mixed
cutaneous tumour). They also proposed five histopatho-
logical criteria for its diagnosis: 1) nests of cuboidal or
polygonal cells; 2) intercommunicating tubuloalveolar
structures lined with two or more rows of cuboidal cells;
3) ductal structures composed of one or two rows of
cuboidal cells; 4) occasional keratinous cysts; 5) a matrix
of varying composition. Chondroid syringomas may have
all five characteristics or manifest only some [1].four cri-
terias were found in our case.
Incidence of CS has been reported as less than 0.01
percent of primary tumors of the skin [4]. CS usually
affects middle-aged or older male patients [4].
Clinically, CS presents typically as a slow growing, pain-
less, firm, non-ulcerated subcutaneous or intracutaneous
nodule. The lesion commonly measures 0.5-3 cm in dia-
meter [5]. However, larger forms of CS have been
described [5].
The sites of predilection for CS are on the head and
neck region, particularly cheek, nose, or skin above the lip
[3,5]. Less commonly, this tumor can develop on the
scalp, eyelid, hand, foot, forehead, axillary region, abdo-
men, penis, vulva, and scrotum [6-8].orbital location is
exceptional. A medline database was questioned using the
key words: CS-orbit, only one case can be found [2].
Kitazawa T and al [2] have reported in 1999 the first
case of a woman complainingo fl e f te x o p h t a l m o sa n d
diplopia, a firm mass was palpable in the left lateral
canthal region, CT and MRI demonstrated a extraconal
mass extending to the malar subcutis and associated with
compression of the globe, the tumor was resected easily
and the diagnosis of benign chondroid syringoma was
confirmed by histopathological examination. No mass
palpable was found in our case.
Histologically, CS consists of mixed epithelial and
mesenchymal elements, with epithelial cells arranged in
cords and forming tubules with a myoepithelial layer, set
in a myxoid or chondroid stroma [4,9]. Osteoid stroma
or mature adipocytes can be present in rare cases [9].
Two histological variants of this tumor are described, the
eccrine type with smaller lumens lined by a single row of
cuboidal epithelial cells and the apocrine variant with
tubular and cystic branching lumina lined by two rows of
epithelial cells [4]. Immunohistochemical study shows
focal positivity for keratin, vimentin, desmin, and S-100
protein in the stroma [4].
Radiological features of CS are not as suggestive as
the histological findings. The MRI features are non-
specific, but can accurately depict the anatomic extent
and identify tissue of origin, depth of invasion and
relation to adjacent structures, such as muscles and
bones [10].
The differential diagnosis of CS is made with other
benign orbital lesions include pleomorphic adenoma,
dermoids, lipomas, neurofibromas, meningioma, lym-
phangiomas, Cavernous hemangiomas and histiocytic
tumors. [11]. We describe our patient to point out that
this tumor should be considered a rare possibility in the
differential diagnosis of orbital tumors. CS lesions
usually are not clinically or radiology distinctive and the
diagnosis is made on histological examination [3,4].
The treatment of choice is complete excision without
esthetic or functional disruption of surrounding struc-
tures [4]. Lateral orbitotomy is a safe approach in the
surgical management of lesions in the lateral orbital
region, particularly if the lesions are extraconal [12]. It
has been suggested that incisional biopsy or fine-needle
aspiration may disrupt the tumor and seed local tissue,
increasing the risk of recurrence. In our observation, the
tumor was completely excised without recurrence within
a 1-year followup.
Chondroid syringoma is a benign tumor. However,
rare cases of malignant CS have been reported [3,13].
These malignant forms occur more commonly in
younger female patients, and have a predilection for
occurring on the trunk or extremities [3,13]. These
tumors often are larger than 3 cm and are locally inva-
sive. Histological findings such as cytologic atypia, infil-
trative margins, satellite tumor nodules, tumor necrosis,
and involvement of deep structures are considered as
signs of malignant transformation [4,14]. Close follow-
up of these tumors is recommended because of risk of
malignancy and recurrence.
Conclusion
Chondroid syringoma should be included in the differ-
ential diagnosis of intraorbital tumors, especially in mid-
dle-aged patients. Although malignant forms and
recurrence are extremely rare, wide excision of the
tumor and long-term followup are the most effective
ways of management.
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